IZINDABA EZINHLE ZE-CHUANGKUN BIOTECH EMAKETHENI YASE-SHANGHAI CHUANGKUN BIOTECH TB/NTM-DNA DETECTION KIT(LYOPHILIZED) IVUNYIWE YI-THAILAND FDA!

Ngosuku olungu-1, u-Februray, i-Shanghai Chuangkun Biotechnology Co., Ltd. ithole isitifiketi sesibili sokubhaliswa kwe-Thailand FDA sekhithi yokuhlonza i-TB/NTM-DNA, sinyathwe yikhithi ye-PCR yohlobo lwe-HPV yohlobo oluyi-15 ngenyanga edlule.eyamemezela ukuthi imikhiqizo ye-Chuangkun Biotech igunyazwe yi-Thailand FDA, yenza ngcono imikhiqizo ezithuthukisayo, futhi inikeze nokusekelwa okuqinile kwe-Chuangkun Biotech ukuze iqhubeke nokwandisa imakethe yamazwe ngamazwe.

Ilinganiselwa ku-10.6 million abantu emhlabeni jikelele abaguliswa yi-TB eyashicilelwa yi-WHO ngo-2021. Izinga elandayo ngo-4.5% ngaphezu konyaka ka-2020. Khonamanjalo abantu abayizigidi eziyi-1.6 babulawa isifo sofuba ngonyaka odlule (okuhlanganisa no-6.7% babephakathi kwabantu abane-HIV) .Ngokwendawo, izigameko eziningi ze-TB ngo-2021 zazisezifundeni ze-WHO eNingizimu-Mpumalanga ye-Asia (45%), e-Afrika (23%) naseWestern Pacific (18%), zinamasheya amancane eMpumalanga Mediterranean (8.1%), emazweni aseMelika. (2.9%) kanye neYurophu (2.2%).Uma kucatshangelwa ubhubhane lwe-COVID-19, ukuvimbela nokulawula isifo sofuba kuya ngokuya kuhlukumeza oHlelweni Lokuqedwa Kwesifo Sofuba lwe-WHO.

Ikhithi yokuthola i-TB/NTM-DNA ye-CHUANGKUN Biotech idalwe ngenqubo ye-lyophilization Le nqubo izoxazulula ububi besikhathi eside bezokuthutha kwekhithi yokutholwa ye-PCR evamile, futhi iletha ukunemba okuhle kakhulu kanye nemiphumela ecacile kakhulu ngaphezu kokusebenziseka kalula.

I-Shanghai Chuangkun Biotechnology Co., Ltd. ithole isitifiketi sesibili sokubhalisa se-Thailand FDA sekhithi yokuthola i-TB/NTM-DNA, esibonisa ukuqashelwa yi-Thailand FDA.I-Chuangkun Biotech izohlanganyela ekuvimbeleni isifo sofuba futhi ilawule ngamandla.